Walaa Elnaiem

Walaa Elnaiem

Auto-generated profile, based on publicly available information

Walaa Elnaiem

Faculty of Medicine, University of Khartoum, Khartoum, Sudan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2022 in Human Psychopharmacology: Clinical and Experimental
Verified
Journal Article
Closed access
WEWalaa Elnaiem
Walaa Elnaiem
ABAmira Yasmine Benmelouka
Amira Yasmine Benmelouka
AEAli Mohamed Naguib Elgendy
Ali Mohamed Naguib Elgendy
MAMahmoud Shaban Abdelgalil
Mahmoud Shaban Abdelgalil
MAMuhamad Zakaria Brimo Alsaman
Muhamad Zakaria Brimo Alsaman
SYShimaa Mohammad Yousof
Shimaa Mohammad Yousof

3 May 2023 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
WEWalaa Mbbs Elnaiem
Walaa Mbbs Elnaiem
AEAbdulhay Mbbs Mohamed Elnour
Abdulhay Mbbs Mohamed Elnour
AKAbubaker E.A. Mbbs Koko
Abubaker E.A. Mbbs Koko
MMMaysa Mbbs Madany
Maysa Mbbs Madany
LHLina Mbbs Hemmeda
Lina Mbbs Hemmeda
Background and aims: Cardiopulmonary bypass (CPB) utilized for cardiac surgeries has been associated with significant mortality and adverse outcomes. The benefits of incorporating nitric oxide (NO) into the CPB circuit have been reported in terms of reduced inflammation, enhanced dynamic circulation, oxygenation, and end-organ function. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of inhaled NO introduced to the CPB circuit among pediatric patients undergoing various cardiac surgeries. Methods: A systematic literature search was conducted on 26 July 2022, using the electronic databases of PubMed, Cochrane, Scopus, and Web of Science to include randomized controlled trials, with no restriction regarding the date of study conduction. The quality of studies was assessed using the Cochrane tool. RevMan 5.3 software was used to analyze data in the inverse variance method, with pooling data as mean difference (MD), risk ratio, and 95% CI. Results: Six trials were included comprising 1666 children who had undergone the interventions of interest. All studies amenable to assessment were of good quality. NO was significantly superior to the control treatments regarding ventilation time (MD=−8.34; 95% CI [−14.50 to −2.17], P=0.008), postoperative interleukin-6 (IL-6) levels (MD=−0.50; 95% CI [−0.54 to −0.46], P<0.001), 24-h IL-6 levels (MD=−0.30; 95% CI [−0.32 to −0.20], P<0.001), and 24-h tumor necrosis factor-alpha (TNF-α) levels (MD=−1.72; 95% CI [−3.44 to −1.00], P=0.05). The side effects of NO and the control treatments were comparable (P=0.9). Conclusion: NO administered as part of the CPB circuit during cardiac surgeries is efficacious in terms of reducing ventilation time, postoperative IL-6, and TNF-α levels compared to control, with a comparable safety profile.

13 November 2022 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
MAMohammed Alfatih
Mohammed Alfatih
KAKhabab Mohamed Ahmed
Khabab Mohamed Ahmed
RARadi Tofaha Alhusseini
Radi Tofaha Alhusseini
EHElfatih A. Hasabo
Elfatih A. Hasabo
LHLina Hemmeda
Lina Hemmeda
MSMohannad Abdalfdeel Almahie Shaban
Mohannad Abdalfdeel Almahie Shaban
Since December 2019, an outbreak of severe respiratory infection (COVID-19) emerged in the city of Wuhan in China. The knowledge, awareness and practice of medical students toward COVID-19 pandemic is of most importance as it demonstrates their preparedness to deal with this pandemic. The objective of this study is to assess the knowledge, awareness and practice of medical students in Sudan universities about COVID 19. This is a cross-sectional study conducted on 19 universities that have medical schools in Sudan. Data from at least 100 medical students from each university were included in the study. Data were collected using an online questionnaire in April 2020. Statistical analysis was conducted using the Statistical Package for Social Science software, version 25. About 2603 medical students from 19 universities were included. Overall good knowledge and practice were demonstrated by the medical students (88.9%) and (78.6%), respectively. Respondents who answered that the most common clinical symptoms of COVID-19 were the main combination of dry cough, fatigue and fever were (27.7%), and the first initial symptom was headache were (48.3%.). (60.2%) Wear medical masks, (95%) said that avoiding crowded places protects against the spread of COVID-19, and (50.7%) have confidence that Sudan can win the battle against the COVID-19. Finally, (68.8%) agreed that COVID-19 will finally be successfully controlled. This study has found that medical students in Sudan demonstrated good knowledge and good practice toward Covid19.

10 July 2022 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
WEWalaa Elnaiem
Walaa Elnaiem
WAWejdan Gad Alsaid Alhussain
Wejdan Gad Alsaid Alhussain
MSMugahid A. Salih
Mugahid A. Salih
Introduction: The accessory brachial artery is a rare arterial variation of the upper limb. It was observed in 0.1-0.8% of upper extremities. In comparison with the brachial artery, the accessory brachial artery has a narrow caliber. Case presentation: During dissection of an old African male cadaver, the brachial artery was observed bifurcating into accessory brachial artery medially and main brachial artery laterally. These two arteries then rejoined in the cubital fossa, forming a common stem, which bifurcated directly into radial and ulnar arteries. Clinical discussion: Detailed knowledge about such arterial variation is clinically essential for angiographic images evaluation, trans-ulnar or trans-radial coronary catheterization, venipuncture, traumatic injuries and fracture management, and many other procedures in the arm or the forearm. Conclusion: The accessory brachial artery is a rare upper limb arterial variation. Knowing such variation is essential for medical workers, especially for surgeons and radiologists.

17 October 2023 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
MEMohammed Mahmmoud Fadelallah Eljack
Mohammed Mahmmoud Fadelallah Eljack
WEWalaa Elnaiem
Walaa Elnaiem
AAAya Elsayed Abdelwahed
Aya Elsayed Abdelwahed
EHElfatih A. Hasabo
Elfatih A. Hasabo
AAAzza A. Abbas
Azza A. Abbas
MCMiddle East Collaborators
Middle East Collaborators
Background: Monkeypox is a zoonotic disease caused by the monkeypox virus, an Orthopox virus. The 2022 monkeypox outbreak provoked fear among the public. Public awareness about the disease could be an important factor in its control. The authors conducted this study to assess the perception and prediction of monkeypox among the Middle East public. Methods: This cross-sectional study was conducted in August 2022. Data were conveniently collected from eight Middle Eastern countries using an online self-administered questionnaire distributed through educational and social media platforms. Statistical analysis was conducted using R software. Results: Approximately 11 016 individuals participated in this study. The participants’ overall knowledge score indicated poor knowledge about monkeypox. Most of the participants knew the causative organism (66.7%). However, numerous participants were not aware of the disease mode of transmission, symptoms, complications, and vaccination. Participants’ awareness was mostly gained from social media (61.8%). The majority predicted acquiring monkeypox when protective measures are not taken (72.7%), progression to a pandemic with economic consequences (50.8 and 52%, respectively), and the ability of the Ministry of Health to control the epidemic (51.5%). Conclusion: In the Middle East, public knowledge about monkeypox is poor. Raising awareness about monkeypox would be of benefit in controlling the epidemic. This study constitutes evidence upon which health education programs could be designed.

27 February 2026 in International Journal of Cardiology Cardiovascular Risk and Prevention
Verified
Journal Article
Open access
EHElfatih A. Hasabo
Elfatih A. Hasabo
SASalma S. Alrawa
Salma S. Alrawa
AEAmmar Tarig Elgadi
Ammar Tarig Elgadi
AAAlaa S. Ahmed
Alaa S. Ahmed
EAEsraa Salaheldin Ahmed Alfadul
Esraa Salaheldin Ahmed Alfadul
OSOsama Soliman
Osama Soliman
Severe aortic stenosis (AS) imposes chronic pressure overload on the left ventricle (LV), leading to adverse remodeling and systolic dysfunction. While transcatheter aortic valve implantation (TAVI) can reverse this process, the overall prevalence and predictors of LV functional recovery are not fully understood. This study aims to assess the left ventricular ejection fraction (LVEF) recovery following TAVI. A meta-analysis was conducted in accordance with PRISMA guidelines. The PubMed, Scopus, Web of Science, and Cochrane databases were searched from inception through November 2024 for studies reporting on LVEF improvement after TAVI in patients with severe AS. The primary outcome was LVEF improvement, defined as an absolute increase of ≥10% from baseline. A random-effects model was employed for all pooled analyses to account for inter-study heterogeneity. Eighteen studies encompassing 4782 patients met the inclusion criteria. In the subgroup of patients with reduced LVEF, 14 studies with a total of 3182 patients reported a LV systolic recovery of 49% (95% CI: 40-57; I2 = 97%). The recovery was observed across all follow-up periods, from immediately post-procedure to one-year. A meta-regression has identified that baseline LVEF is a predictor of LV systolic recovery (β = −0.042 (95% CI: [-0.075, −0.008], p = 0.018, I2 = 93.31%). TAVI is associated with substantial LV systolic recovery in nearly half of all patients with pre-existing systolic dysfunction. These findings underscore the prognostic importance of myocardial recovery in this high-risk patient population and can inform clinical decision-making and patient counseling.